Adam P. Silverman PhD, BS

Adam P. Silverman is the Group Leader for Protein Engineering at Denali Therapeutics, where his lab focuses on engineering large molecules to cross the BBB, as well as discovery and optimization of therapeutic antibodies and proteins. Adam previously worked in the Antibody Discovery and Engineering group at Takeda California. He received his postdoctoral training in bioengineering at Stanford University in the lab of Jennifer Cochran, and his Ph.D. and undergraduate training at Stanford and MIT, respectively.